Trial Profile
Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-Lumefantrine and Nevirapine-Based Antiretrovirals in HIV-Infected Patients With Uncomplicated Falciparum-Malaria in Muheza, Northeastern Tanzania.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Antiretrovirals; Nevirapine
- Indications HIV-1 infections; Malaria
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms InterACT
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.